Skip to content

FDA committee recommends approval of maraviroc for first-line treatment in US

CD4 cell count below 500 increases cancer risk for patients with HIV

Water treatment does not reduce diarrhoea in infants born to Kenyan mothers with HIV

South Africa: HIV rate among pregnant women stays high, HIV rates varied widely between districts

Mobile phone attachment costing US$10 could be used for CD4 counting

Virologic response to HIV treatment differs by race among US patients

Food insecurity increases risk of death for patients taking HIV treatment in Canada

Patients often perceive no risk if they delay attending STI clinics

Topical treatment for pre-cancerous anal cell changes safe and moderately effective